Related Experiment Video

Updated: May 26, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Apoptosis in Anthracycline Cardiomyopathy

Jianjian Shi1, Eltyeb Abdelwahid, Lei Wei

  • 1Riley Heart Research Center, Wells Center for Pediatric Research, Department of Pediatrics Indiana University, School of Medicine, Indianapolis, Indiana, USA.

Current Pediatric Reviews
|January 4, 2012
PubMed

Insights

Anthracyclines cause heart damage by inducing programmed cell death (apoptosis) in cardiomyocytes. This review explores anthracycline-induced apoptosis and its implications for cardiac health and treatment strategies.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pharmacology

Background:

  • Apoptosis, or programmed cell death, is a critical physiological process.
  • Anthracycline chemotherapy is known to cause cardiotoxicity, with cardiomyocyte apoptosis and necrosis being key contributors to its progression.
  • Evidence indicates that both intrinsic and extrinsic apoptotic pathways are activated in the heart by anthracyclines.

Purpose of the Study:

  • To review the current understanding of anthracycline-induced apoptotic cell death in the heart.
  • To discuss novel strategies targeting cardiotoxic mechanisms and apoptotic pathways.
  • To examine differences in sensitivity to anthracycline-induced apoptosis between young and adult hearts.

Main Methods:

  • Literature review of in vitro and in vivo studies.
  • Analysis of evidence on apoptotic pathway activation.
  • Discussion of implications for animal models and pharmacological effects.

Main Results:

  • Anthracycline-induced apoptosis is a significant factor in cardiotoxicity.
  • Various cardiotoxic mechanisms and apoptotic pathways are influenced by anthracyclines.
  • Differential sensitivity to anthracycline-induced apoptosis exists between young and adult hearts.

Conclusions:

  • Anthracycline-induced apoptosis is a valid model for studying cardiotoxicity.
  • Understanding these pathways is crucial for developing new therapeutic strategies.
  • Age-related differences in cardiac sensitivity to anthracyclines warrant further investigation.

More Related Videos

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

Related Concept Videos

Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...